using both lung cancer samples and mouse models, that aged Treg cells express higher levels of an ER enzyme, SOAT2, have altered cholesterol metabolism, and induce CD8 + T cell senescence to ...
Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...
The French biotech company Nanobiotix announced today that it has dosed the first patient in the CONVERGE study, a Phase 2 ...
Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.
A new deep learning model shows promise in detecting and segmenting lung tumors. The findings of the study could have ...
Amgen (AMGN) stock in focus as U.S. approval for its lung cancer drug expands for metastatic colorectal cancer. Read more ...
News Medical on MSN7d
Ultrasensitive ctDNA detection improves risk prediction in early-stage lung cancerUltrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...
Chavez, MD, discusses how comprehensive genomic profiling may impact the treatment and clinical management of patients with small cell lung cancer.
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...
Tevimbra is under clinical development by BeiGene and currently in Phase I for Urethral Cancer. According to GlobalData, Phase I drugs for Urethral Cancer does not have sufficient historical data to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback